Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssetco Regulatory News (ASTO)

  • There is currently no data for ASTO

Director/PDMR Shareholding

21 Jun 2023 16:53

RNS Number : 4961D
AssetCo PLC
21 June 2023
 

21 June 2023

LEI: 213800LFMHKVNTZ7GV45

 

AssetCo plc ("AssetCo" or the "Company")

 

NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND OF PERSONS CLOSELY ASSOCIATED ("PCA")

 

The Company announces that it has received notification that Harwood Capital Limited, investment manager to North Atlantic Smaller Companies Investment Trust PLC and PCA to Christopher Mills, a Director of the Company, has purchased ordinary shares in the Company ("Shares") on 20 June 2023.

 

PDMR

PDMR/PCA

Number of Shares purchased

Share price

Christopher Mills

Harwood Capital Limited

850,000

£0.35

 

 

Formal notifications in respect of the PDMR and the PCA are set out below in accordance with the requirements of the Market Abuse Regulation.

 

For further information, please contact:

AssetCo plc

Gary Marshall, CFOO

Tel: +44 (0) 7788 338157

Numis Securities Limited

Nominated adviser and joint broker

Giles Rolls / Charles Farquhar

Tel: +44 (0) 20 7260 1000

 

 

Panmure Gordon (UK) Limited

Joint broker

Atholl Tweedie

Tel: +44 (0) 20 7886 2906

H/Advisors Maitland

Neil Bennett

Rachel Cohen

Tel: +44 (0) 20 7379 55151

For further details, visit the website, www.assetco.com

Ticker: AIM: ASTO.L

 

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

 

 

Harwood Capital Limited, PCA to Christopher Mills

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PCA to PDMR

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

AssetCo plc

b)

 

LEI

 

 

213800LFMHKVNTZ7GV45

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of £0.01 each

Identification code

GB00BQ2K3557

b)

 

Nature of the transaction

 

 

Purchase of Shares

c)

 

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

£0.35

850,000

 

 

d)

 

Aggregated information

- Aggregated volume

850,000

- Price

 

£297,500

 

 

e)

 

Date of the transaction

 

 

20 June 2023

f)

 

Place of the transaction

 

 

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDZGZVKMRGFZM
Date   Source Headline
1st Apr 20207:00 amRNSAnnual Report and Accounts and Notice of AGM
27th Feb 20207:00 amRNSPreliminary results - year ended 30 September 2019
10th Oct 20195:04 pmRNSHolding(s) in Company
10th Oct 20195:02 pmRNSDirector/PDMR Shareholding
20th Jun 20197:00 amRNSHalf-year Report- six months ended 31 March 2019
31st May 20197:00 amRNSLitigation update
8th May 20197:00 amRNSResult of AGM
8th Apr 20197:00 amRNSNotice of AGM
25th Mar 20193:20 pmRNSAnnual Financial Report
18th Mar 20197:00 amRNSPreliminary results - year ended 30 September 2018
4th Mar 201912:51 pmRNSHolding(s) in Company
25th Feb 20193:15 pmRNSLitigation Update
31st Jan 20194:41 pmRNSSecond Price Monitoring Extn
31st Jan 20194:36 pmRNSPrice Monitoring Extension
31st Jan 20199:24 amRNSLitigation Update
21st Dec 20184:11 pmRNSTrade Update
16th Oct 201811:22 amRNSTrade update
27th Jun 20187:00 amRNSHalf-year Report - period ended 31 March 2018
26th Apr 20183:06 pmRNSResult of AGM
4th Apr 20187:55 amRNSAnnual Financial Report & Notice of AGM
28th Mar 20187:00 amRNSPreliminary Results - year to 30 September 2017
2nd Oct 20177:00 amRNSHolding(s) in Company
13th Jun 20177:00 amRNSHalf-year Report - six months ended 31 March 2017
5th May 20173:32 pmRNSResult of AGM
28th Mar 20177:00 amRNSPreliminary Results - year to 30 September 2016
31st Jan 20171:50 pmRNSContract update
30th Dec 20167:00 amRNSContract update
17th Nov 20167:00 amRNSContract update
24th Jun 20167:00 amRNSDirectorate announcement
14th Jun 20167:00 amRNSHalf-year Report - six months ended 31 March 2016
17th May 201612:58 pmRNSResult of AGM
24th Mar 201610:35 amRNSPreliminary results - year to 30 September 2015
16th Dec 20151:55 pmRNSStatement re: claim against former auditors
15th Jul 20157:00 amRNSDirector Dealing
19th Jun 20157:00 amRNSHalf Yearly Report - period ended 31 March 2015
20th May 20153:16 pmRNSResult of AGM
30th Apr 201510:19 amRNSNotice of AGM
26th Mar 20157:00 amRNSPreliminary results - year ended 30 September 2014
22nd Jul 201410:45 amRNSNew Contract signed with Abu Dhabi Government
30th Jun 20147:00 amRNSHalf Yearly Report -six months to 31 March 2014
28th Mar 20147:16 amRNSPreliminary Results - year to 30 September 2013
15th Jan 20145:05 pmRNSHolding(s) in Company
3rd Jan 20141:43 pmRNSIssue of Equity
17th Dec 201310:39 amRNSStatement re Director obituary
27th Jun 20137:00 amRNSHalf-Year Results 6 month period ended 31/3/2013
22nd Mar 201312:00 pmRNSAnnual General Meeting
25th Feb 20134:22 pmRNSAnnual Financial Report
20th Dec 20127:00 amRNSPreliminary Results - Year to 30 September 2012
12th Dec 20122:48 pmRNSHolding(s) in Company
11th Dec 20123:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.